Sudden Sensorineural Hearing Loss after Third Dose Booster of COVID-19 Vaccine Administration
Federica Zoccali,
Francesca Cambria,
Andrea Colizza,
Massimo Ralli,
Antonio Greco,
Marco de Vincentiis,
Carla Petrella,
Marco Fiore,
Antonio Minni,
Christian Barbato
Affiliations
Federica Zoccali
Department of Sense Organs, Sapienza University of Rome, 00161 Roma, Italy
Francesca Cambria
Department of Sense Organs, Sapienza University of Rome, 00161 Roma, Italy
Andrea Colizza
Department of Sense Organs, Sapienza University of Rome, 00161 Roma, Italy
Massimo Ralli
Department of Sense Organs, Sapienza University of Rome, 00161 Roma, Italy
Antonio Greco
Department of Sense Organs, Sapienza University of Rome, 00161 Roma, Italy
Marco de Vincentiis
Department of Sense Organs, Sapienza University of Rome, 00161 Roma, Italy
Carla Petrella
Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico 155, 00161 Roma, Italy
Marco Fiore
Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico 155, 00161 Roma, Italy
Antonio Minni
Department of Sense Organs, Sapienza University of Rome, 00161 Roma, Italy
Christian Barbato
Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico 155, 00161 Roma, Italy
Coronavirus disease 2019 (COVID-19) was declared a pandemic due to its rapid spread worldwide, and its vaccination campaign is considered one of the most historic public hygiene measures in modern medicine. Sudden sensorineural hearing loss (SSHL) is a common emergency that affects patient’s quality of life and requires rapid treatment with steroids. The etiology could be viral or vascular even though in most cases it remains unknown (idiopathic SSHL). During the SARS-CoV-2 vaccination campaign, several rare but serious adverse events have been reported including thrombosis with thrombocytopenia syndrome, myocarditis, and Guillain-Barré Syndrome. ENT adverse events after vaccination were reported too, including cases of sudden sensorineural hearing loss (SSHL), vestibular neuronitis and audio vestibular disorders (such as tinnitus, dizziness, and vertigo). For the first time here, we reported two cases of SSHL after third administration of COVID-19 mRNA vaccine. Even if there is not clear evidence of an association between SSHL and vaccination, adverse effects should be kept in mind since viral infection could be the etiology of SSHL.
